2 false false false false false false false false false false true false false false false false false No description of principal activity 2024-01-01 Sage Accounts Production Advanced 2024 - FRS102_2024 24,931 4,989 29,920 18,772 5,784 24,556 5,364 6,159 xbrli:pure xbrli:shares iso4217:GBP SC559704 2024-01-01 2024-12-31 SC559704 2024-12-31 SC559704 2023-12-31 SC559704 2023-04-01 2023-12-31 SC559704 2023-12-31 SC559704 2023-03-31 SC559704 bus:Director1 2024-01-01 2024-12-31 SC559704 core:PlantMachinery 2023-12-31 SC559704 core:PlantMachinery 2024-12-31 SC559704 core:PlantMachinery 2024-01-01 2024-12-31 SC559704 core:WithinOneYear 2024-12-31 SC559704 core:WithinOneYear 2023-12-31 SC559704 core:ShareCapital 2024-12-31 SC559704 core:ShareCapital 2023-12-31 SC559704 core:RetainedEarningsAccumulatedLosses 2024-12-31 SC559704 core:RetainedEarningsAccumulatedLosses 2023-12-31 SC559704 core:PlantMachinery 2023-12-31 SC559704 bus:SmallEntities 2024-01-01 2024-12-31 SC559704 bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 SC559704 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 SC559704 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 SC559704 bus:FullAccounts 2024-01-01 2024-12-31
COMPANY REGISTRATION NUMBER: SC559704
Augur Precision Medicine Limited
Filleted Unaudited Financial Statements
31 December 2024
Augur Precision Medicine Limited
Financial Statements
Year ended 31 December 2024
Contents
Page
Balance sheet
1
Notes to the financial statements
3
Augur Precision Medicine Limited
Balance Sheet
31 December 2024
2024
2023
Note
£
£
£
£
Fixed assets
Tangible assets
5
5,364
6,159
Current assets
Debtors
6
30,891
21,524
Cash at bank and in hand
4,577
1,930
--------
--------
35,468
23,454
Creditors: amounts falling due within one year
7
15,768
21,619
--------
--------
Net current assets
19,700
1,835
--------
-------
Total assets less current liabilities
25,064
7,994
Provisions
Taxation including deferred tax
1,019
1,170
--------
-------
Net assets
24,045
6,824
--------
-------
Augur Precision Medicine Limited
Balance Sheet (continued)
31 December 2024
2024
2023
Note
£
£
£
£
Capital and reserves
Called up share capital
1
1
Profit and loss account
24,044
6,823
--------
-------
Shareholders funds
24,045
6,824
--------
-------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the profit and loss account has not been delivered.
For the year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 12 May 2025 , and are signed on behalf of the board by:
Prof J Timmons
Director
Company registration number: SC559704
Augur Precision Medicine Limited
Notes to the Financial Statements
Year ended 31 December 2024
1. General information
The company is a private company limited by shares, registered in Scotland. The address of the registered office is 7 Westerton Drive, Bridge Of Allan, Stirling, FK9 4AX.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis and in sterling, which is the functional currency of the entity.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for goods supplied and services rendered, stated net of discounts and of Value Added Tax.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Current tax is recognised on taxable profit for the current and past periods. Deferred tax is recognised in respect of all timing differences at the reporting date.
Foreign currencies
Foreign currency transactions are initially recorded in the functional currency, by applying the spot exchange rate as at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated at the exchange rate ruling at the reporting date, with any gains or losses being taken to the profit and loss account.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Plant and machinery
-
3 years
4. Employee numbers
The average number of persons employed by the company during the year amounted to 2 (2023: 2 ).
5. Tangible assets
Plant and machinery
£
Cost
At 1 January 2024
24,931
Additions
4,989
--------
At 31 December 2024
29,920
--------
Depreciation
At 1 January 2024
18,772
Charge for the year
5,784
--------
At 31 December 2024
24,556
--------
Carrying amount
At 31 December 2024
5,364
--------
At 31 December 2023
6,159
--------
6. Debtors
2024
2023
£
£
Trade debtors
15,996
14,461
Other debtors
14,895
7,063
--------
--------
30,891
21,524
--------
--------
7. Creditors: amounts falling due within one year
2024
2023
£
£
Social security and other taxes
647
1,397
Other creditors
15,121
20,222
--------
--------
15,768
21,619
--------
--------
8. Directors' advances, credits and guarantees
During the year, the directors had interest-free, repayable on demand loans. At the start of the year the company owed them £14,280 and at the end of the year they owed the company £4,432.